Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

FDA classification

FDA Class 2 ·Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

Test, Factor V Leiden Mutations, Genomic Dna Pcr

FDA classification

FDA Class 2 ·Test, Factor V Leiden Mutations, Genomic Dna Pcr

Analyzer, Chromosome, Automated

FDA classification

FDA Class 2 ·Analyzer, Chromosome, Automated

Tissue Rna Preservative For Collection, Storage, And Transportation

FDA classification

FDA Class 2 ·Tissue Rna Preservative For Collection, Storage, And Transportation

Ige, Peroxidase, Antigen, Antiserum, Control

FDA classification

FDA Class 2 ·Ige, Peroxidase, Antigen, Antiserum, Control

System, Automated Scanning Microscope And Image Analysis For Fluorescence In Situ Hybridization (Fish) Assays

FDA classification

FDA Class 2 ·System, Automated Scanning Microscope And Image Analysis For Fluorescence In Situ Hybridization (Fish) Assays

System, Test, (Ihc), Tumor Marker, Monitoring, Bladder Cancer

FDA classification

FDA Class 2 ·System, Test, (Ihc), Tumor Marker, Monitoring, Bladder Cancer

Chronic Lymphocytic Leukemia Fish Probe Kit

FDA classification

FDA Class 2 ·Chronic Lymphocytic Leukemia Fish Probe Kit

System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations

FDA classification

FDA Class 2 ·System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations

Bcr/Abl1 Monitoring Test

FDA classification

FDA Class 2 ·Bcr/Abl1 Monitoring Test

Control Material, Her-2/Neu, Immunohistochemistry

FDA classification

FDA Class 2 ·Control Material, Her-2/Neu, Immunohistochemistry

Dna Fish Probe Kit For Specimen Characterization, Human Chromosome, Hematological Disorders

FDA classification

FDA Class 2 ·Dna Fish Probe Kit For Specimen Characterization, Human Chromosome, Hematological Disorders

System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection

FDA classification

FDA Class 2 ·System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection

Circulating Tumor Cell (Ctc) Enrichment Device

FDA classification

FDA Class 2 ·Circulating Tumor Cell (Ctc) Enrichment Device

Classifier, Prognostic, Recurrence Risk Assessment, Rna Gene Expression, Breast Cancer

FDA classification

FDA Class 2 ·Classifier, Prognostic, Recurrence Risk Assessment, Rna Gene Expression, Breast Cancer

Igm, Peroxidase, Antigen, Antiserum, Control

FDA classification

FDA Class 2 ·Igm, Peroxidase, Antigen, Antiserum, Control

Igg, Peroxidase, Antigen, Antiserum, Control

FDA classification

FDA Class 2 ·Igg, Peroxidase, Antigen, Antiserum, Control

Immunohistochemistry Assay, Antibody, Progesterone Receptor

FDA classification

FDA Class 2 ·Immunohistochemistry Assay, Antibody, Progesterone Receptor

System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection

FDA classification

FDA Class 2 ·System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection

Autosomal Recessive Carrier Screening Gene Mutation Detection System

FDA classification

FDA Class 2 ·Autosomal Recessive Carrier Screening Gene Mutation Detection System